Related Experiment Video
Updated: Jul 18, 2026

In vivo Evaluation of Mucociliary Clearance in Mice
Published on: December 18, 2020
Single dose oral ranitidine improves MRCP image quality: a double-blind study.
M T Bowes1, D F Martin, A Melling
1South Manchester University Hospitals NHS Trust, Wythenshawe, Manchester, UK.
A single oral dose of ranitidine before magnetic resonance cholangiopancreatography (MRCP) significantly reduces stomach and duodenum signal. This improves the visibility of the biliary tree, aiding in diagnosis.
Area of Science:
- Radiology
- Gastroenterology
- Pharmacology
Background:
- Magnetic resonance cholangiopancreatography (MRCP) is a key imaging technique for evaluating the biliary tree.
- Signal from the stomach and duodenum can obscure visualization of the distal common bile duct.
Purpose of the Study:
- To assess if a single 300 mg oral dose of ranitidine can reduce upper gastrointestinal signal.
- To determine if ranitidine improves the conspicuity of the biliary tree during MRCP.
Main Methods:
- A double-blind, placebo-controlled, randomized crossover trial involving 35 volunteers.
- MRCP was performed using a 1.5 T MRI scanner.
- Examinations were scored by experienced consultants for image quality.
Main Results:
- Ranitidine significantly decreased signal intensity in the stomach and duodenum (p<0.0005).
- Conspicuity of the distal and proximal common bile duct significantly increased (p<0.033 and p<0.010, respectively).
- No adverse effects were reported.
Conclusions:
- Ranitidine is an effective and inexpensive agent for reducing upper gastrointestinal signal.
- Oral ranitidine enhances the visibility of the biliary tree in MRCP examinations.
Related Concept Videos
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Imaging Studies for Cardiovascular System IV: CMRI
Imaging Studies V: Intravenous Urography and Retrograde Pyelography